Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance

Ahmad N 1 , Javaid A 2 , Basit A 2 , Afridi AK 2 , Khan MA 3 , Ahmad I 4 Show all authors , Sulaiman SA 1 , Khan AH 1

Affiliations 

  • 1 Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
  • 2 Department of Pulmonology, Postgraduate Medical Institute, Peshawar
  • 3 Peshawar Medical College, Peshawar
  • 4 Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan
Int J Tuberc Lung Dis, 2015 Sep;19(9):1109-14, i-ii.
PMID: 26260834 DOI: 10.5588/ijtld.15.0167

Abstract

Although Pakistan has a high burden of multidrug-resistant tuberculosis (MDR-TB), little is known about the management and treatment outcomes of MDR-TB patients in Pakistan.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications